ARCHIVES

Research Program For Biological Response Modifiers Outlined By DCT board Subcommittee

This article is from The Cancer Letter archive.

Vol. 05 No. 46 | November 16, 1979

Download PDF Visit The Full Archive

Related Articles

In Brief: Megastrol Acetate Still Under FDA Review; Mays Hired For NCI’s Technology Office

July 20, 1990

Vitamin D Not Associated With Risk For Less Common Cancers, Study Finds

July 30, 2010

Cancer Centers: John Glick to step down after 21 years directing Penn’s Abramson Cancer Center.

December 2, 2005

Phase 1 AIDS Vaccine Trial Will Involve 81 Persons At NIH

August 28, 1987

New Protocol Could Improve Survival Of Rare Brain Tumor

October 30, 2009

Schilskly Promoted to Associate Dean At Chicago, Vogelzang To Direct Center

March 5, 1999